ISC 2026 | NIH StrokeNet: ongoing work and getting involved

So the NIH StrokeNet is funded by the National Institute of Neurological Diseases and Stroke, and we’ve been active since 2013. We are very well organized in the United States, and we also have global sites that we work with as well as part of our studies. What we’re focused on are treatments, acute treatments, prevention of stroke and stroke recovery, and also looking at markers or biomarkers that can help in these different trials that we do. And we do Phase II, which are kind of exploratory trials and also big Phase III trials. And we’ve done now, believe it or not, 29 trials that we’ve been doing since 2013, some of which already have changed practice in stroke. And we’re very excited. It’s a great group. We have 27 regional centers in the country, which are like a hub and spoke. They have a lot of other sites. And we have about 300 sites that have actually enrolled in our studies in the United States or other countries. Now, when you ask how you get involved, well, a lot of the stroke physicians in our U.S. sites, they’re often probably part already of a StrokeNet site or a StrokeNet hub, and so they’re involved right now. But if they are interested in participating in trials, they can get hold of one of those research centers, or they can get hold of one of us at the National Coordinating Center, which is at the University of Cincinnati. And the Data Management and the Statistical Center is at the Medical University of South Carolina. And again, we partner with the NINDS to do all the work we do. So it’s been a wonderful, wonderful adventure. We’ve accomplished a great deal. I think we’re the largest probably network for clinical trials funded by the government, and we’ve made a lot of impact already.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.